Crossmark

Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer

Crossref DOI link: https://doi.org/10.15252/emmm.201708253

Published Online: 2021-06-14

Published Print: 2021-07-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Khan, Kabir A https://orcid.org/0000-0001-8453-3485
Wu, Florence TH https://orcid.org/0000-0002-6439-4606
Cruz‐Munoz, William

Kerbel, Robert S https://orcid.org/0000-0002-6015-2570
Funding

Funding for this research was provided by:

Canadian Institutes of Health Research (PJT 148542)

Canadian Cancer Society

Worldwide Cancer Research (14‐1329)

University of Toronto
License Information

Version of Record valid from 2021-06-14
More Information

Publication History

Received: 2017-07-12

Accepted: 2021-03-11

Published: 2021-06-14